Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-24T03:43:53.900Z Has data issue: false hasContentIssue false
  • English
  • Français

Question-and-Answer Session

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Expert Panel Supplement
Information
CNS Spectrums , Volume 14 , Issue S5: Efficacy, Safety, and Tolerability Considerations in the Novel Treatment of Major Depressive Disorder , March 2009 , pp. 17 - 18
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Franz, B, Kupfer, DJ, Miewald, JM, Jarrett, DB, Grochocinski, VJ. Growth hormone secretion timing in depression: clinical outcome comparisons. Biol Psychiatry. 1995;38(11):720–729.CrossRefGoogle ScholarPubMed
2.Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.Google Scholar
3.Lydiard, RB, Brawman-Mintzer O. Anxious depression. J Clin Psychiatry. 1998;59(suppl 18):10–17.Google ScholarPubMed
4.MacQueen, GM, Campbell, S, McEwen, BS, et al. Course of illness, hippocampal function, and hip-pocampal volume in major depression. Proc Natl Acad Sci USA. 2003;100(3):1387–1392.CrossRefGoogle Scholar
5.Parker, G, Hadzi-Pavlovic, D, Wilhelm, K, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994;164(3):316–326.CrossRefGoogle ScholarPubMed